KPMG: China's pharmaceutical market will set off a wave of M & A in 2013

Source: FDC pharmasia news 2013-04-27 KPMG According to a new report released by its consulting company, given that China is expected to become a global leader in drug discovery and innovation in the next decade, enterprises also hope to fill the gaps in the scattered market sectors, and the demand is still strong, so it is expected that there will be a wave of mergers, acquisitions and joint ventures in the Chinese market KPMG expects China's drug spending to grow by 18-20% by 2015 Relevant driving factors include relatively strong economic growth, growing middle class, strong government support, urbanization, lifestyle change, aging population and increased demand for high-quality health care products KPMG said that from 2014 to 2015, China will "generate pharmaceutical market opportunities worth more than 500 billion US dollars" At present, China has accounted for 5.6% of the global pharmaceutical industry Both government and private spending are expected to maintain steady growth through 2016.